Open Access

Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: A mechanistic model supporting prevention strategies

  • Authors:
    • Helen Lin
    • Jian-Ping Lu
    • Pierre Laflamme
    • Shengjun Qiao
    • Bobby Shayegan
    • Inna Bryskin
    • Lauren Monardo
    • Brian C. Wilson
    • Gurmit Singh
    • Jehonathan H. Pinthus
  • View Affiliations

  • Published online on: October 1, 2010     https://doi.org/10.3892/ijo_00000725
  • Pages: 761-766
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Oxidation of mitochondrial fatty acids (FA) results in the generation of reactive oxygen species (ROS) which have been postulated to play a key role in the initiation and progression of prostate cancer (PC). We previously reported that androgens increase FA uptake into PC cells. We thus examined if androgens that are known to induce ROS generation regulate FA oxidation in PC cells. The effects of the androgen-depleted medium, R1881 (synthetic androgen) and/or androgen receptor blocker, bicalutamide were examined in the human androgen-responsive but not dependent 22rv1 cells. R1881 supplementation significantly increased mitochondrial FA oxidation (14C-radiolabeled FA degradation studies), resulting in increased ROS production. Androgens increased the mRNA levels of carnitine palmitoyltransferase (CPT1), the rate limiting enzyme in the process of mitochondrial FA oxidation. Treatment with R1881 and bicalutamide inhibited these androgen regulated effects. Inhibition of mitochondrial ROS generation by two different inhibitors, rotenone and thenoyltrifluoroacetone, eliminated the androgen-induced ROS generation, to the same level as in cells deprived of androgens or treated with R1881 and bicalutamide. Taken together, androgens increase the mitochondrial oxidation of FA, leading to increased production of ROS that is associated with prostate cell proliferation and mutagenesis. These results therefore support the rationale for PC prevention using 5-α reductase inhibitors, dietary restrictions or anti-oxidants, each of which has different inhibitory but complementary effects.

Related Articles

Journal Cover

October 2010
Volume 37 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Lin H, Lu J, Laflamme P, Qiao S, Shayegan B, Bryskin I, Monardo L, Wilson BC, Singh G, Pinthus JH, Pinthus JH, et al: Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: A mechanistic model supporting prevention strategies. Int J Oncol 37: 761-766, 2010.
APA
Lin, H., Lu, J., Laflamme, P., Qiao, S., Shayegan, B., Bryskin, I. ... Pinthus, J.H. (2010). Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: A mechanistic model supporting prevention strategies. International Journal of Oncology, 37, 761-766. https://doi.org/10.3892/ijo_00000725
MLA
Lin, H., Lu, J., Laflamme, P., Qiao, S., Shayegan, B., Bryskin, I., Monardo, L., Wilson, B. C., Singh, G., Pinthus, J. H."Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: A mechanistic model supporting prevention strategies". International Journal of Oncology 37.4 (2010): 761-766.
Chicago
Lin, H., Lu, J., Laflamme, P., Qiao, S., Shayegan, B., Bryskin, I., Monardo, L., Wilson, B. C., Singh, G., Pinthus, J. H."Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: A mechanistic model supporting prevention strategies". International Journal of Oncology 37, no. 4 (2010): 761-766. https://doi.org/10.3892/ijo_00000725